Andrea Wang
Overview
Explore the profile of Andrea Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
3148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guttman-Yassky E, Simpson E, Bissonnette R, Eichenfield L, Kabashima K, Luna P, et al.
Immunotherapy
. 2025 Feb;
17(2):83-94.
PMID: 40012373
Atopic dermatitis (AD) is a chronic inflammatory disease affecting ~ 10% of adults and ~ 20% of children globally. Many patients with moderate-to-severe AD receiving systemic therapies, including biologics and...
2.
Kim Y, Wang A, Christos P, Valente K, Reisacher W
Int Forum Allergy Rhinol
. 2023 Nov;
14(4):873-875.
PMID: 37922236
This is the first study to quantify the accuracy, sensitivity, and specificity of the human olfactory system in detecting peanuts in common food items. With more competing sensory input, the...
3.
Thulien N, Hwang S, Kozloff N, Nisenbaum R, Akdikmen A, Fambegbe O, et al.
Can J Public Health
. 2023 Jul;
114(6):893-905.
PMID: 37462842
Objectives: The overarching objective of this mixed methods longitudinal study was to understand whether and how rent subsidies and mentorship influenced socioeconomic inclusion outcomes for youth exiting homelessness. The focus...
4.
Nazaryan H, Watson M, Ellingham D, Thakar S, Wang A, Pai M, et al.
Syst Rev
. 2023 Jul;
12(1):121.
PMID: 37443063
Background: Abnormal uterine bleeding (AUB), which includes heavy menstrual bleeding (HMB), is a common condition placing women at increased risk for developing iron deficiency and iron deficiency anemia (IDA). Depletion...
5.
Tepper S, Lipton R, Silberstein S, Kudrow D, Ashina M, Reuter U, et al.
Headache
. 2023 Jun;
63(6):730-742.
PMID: 37313616
Objective: Assess the long-term efficacy and safety of erenumab in patients with chronic migraine with acute medication overuse. Background: Overuse of acute medication in patients with chronic migraine has been...
6.
Thulien N, Amiri A, Hwang S, Kozloff N, Wang A, Akdikmen A, et al.
JAMA Netw Open
. 2022 Oct;
5(10):e2238670.
PMID: 36301546
Importance: There have been no published randomized clinical trials with a primary outcome of socioeconomic inclusion for young people who have experienced homelessness. Objective: To explore whether young people exiting...
7.
Wang A, Jawa R, Mackin S, Whynott L, Buchholz C, Childs E, et al.
Harm Reduct J
. 2022 Jul;
19(1):78.
PMID: 35841101
Background: Syringe service programs (SSPs) provide essential harm reduction and prevention services for people who inject drugs in the USA, where SSP coverage is expanding. During the COVID-19 pandemic, US...
8.
Ashina M, Tepper S, Brandes J, Reuter U, Boudreau G, Weatherall M, et al.
Headache
. 2022 May;
62(5):624-633.
PMID: 35593783
Objective: To assess the long-term efficacy and safety of erenumab in the subgroup of patients with chronic migraine (CM) in whom prior preventive treatments had failed (TF) (≥1, ≥2, and...
9.
McAllister P, Turner I, Reuter U, Wang A, Scanlon J, Klatt J, et al.
Headache
. 2021 Nov;
61(10):1553-1561.
PMID: 34841526
Objective: We sought to evaluate temporal response patterns to erenumab treatment in patients with episodic migraine. Background: Although many patients treated with erenumab experience onset of efficacy as early as...
10.
Thulien N, Wang A, Mathewson C, Wang R, Hwang S
PLoS One
. 2021 Aug;
16(8):e0256288.
PMID: 34415951
Background: Longitudinal studies examining the life trajectories of young people after they have exited homelessness have identified concerns with persistent social and economic exclusion, struggles to shake off identities of...